3
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      YAP/TAZ-CDC42 signaling regulates vascular tip cell migration

      research-article

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Significance

          New blood vessel formation is a physiological process seen in development, as well as in wound healing and tumorigenesis. Although the process of blood vasculature formation has been well documented, little is known about the molecular mechanisms that regulate endothelial migration during vascular network formation. In this study, we identified a critical role for Hippo effectors YAP and TAZ in the regulation of vascular network remodeling through controlling endothelial cell (EC) proliferation, filopodia formation, and cell migration. We found a striking cytoplasmic function of YAP in the regulation of EC migration through controlling the Rho family GTPase CDC42 activity. These findings identify a previously unrecognized YAP/TAZ function involved in the vascular network remodeling during angiogenesis.

          Abstract

          Angiogenesis and vascular remodeling are essential for the establishment of vascular networks during organogenesis. Here we show that the Hippo signaling pathway effectors YAP and TAZ are required, in a gene dosage-dependent manner, for the proliferation and migration of vascular endothelial cells (ECs) during retinal angiogenesis. Intriguingly, nuclear translocation of YAP and TAZ induced by Lats1/ 2-deletion blocked endothelial migration and phenocopied Yap/Taz-deficient mutants. Furthermore, overexpression of a cytoplasmic form of YAP (YAPS127D) partially rescued the migration defects caused by loss of YAP and TAZ function. Finally, we found that cytoplasmic YAP positively regulated the activity of the small GTPase CDC42, deletion of which caused severe defects in endothelial migration. These findings uncover a previously unrecognized role of cytoplasmic YAP/TAZ in promoting cell migration by activating CDC42 and provide insight into how Hippo signaling in ECs regulates angiogenesis.

          Related collections

          Most cited references31

          • Record: found
          • Abstract: found
          • Article: not found

          The Crumbs complex couples cell density sensing to Hippo-dependent control of the TGF-β-SMAD pathway.

          The Hippo pathway senses cell density information to control tissue growth by regulating the localization of the transcriptional regulators TAZ and YAP (TAZ/YAP). TAZ/YAP also regulate TGF-β-SMAD signaling, but whether this role is linked to cell density sensing is unknown. Here we demonstrate that TAZ/YAP dictate the localization of active SMAD complexes in response to cell density-mediated formation of polarity complexes. In high-density cell cultures, the Hippo pathway drives cytoplasmic localization of TAZ/YAP, which sequesters SMAD complexes, thereby suppressing TGF-β signaling. We show that during mouse embryogenesis, this is reflected by differences in TAZ/YAP localization, which define regions of active SMAD2/3 complexes. Interfering with TAZ/YAP phosphorylation drives nuclear accumulation of TAZ/YAP and SMAD2/3. Furthermore, we demonstrate that the Crumbs polarity complex interacts with TAZ/YAP, which relays cell density information by promoting TAZ/YAP phosphorylation, cytoplasmic retention, and suppressed TGF-β signaling. Accordingly, disruption of the Crumbs complex enhances TGF-β signaling and predisposes cells to TGF-β-mediated epithelial-to-mesenchymal transitions. Copyright © 2010 Elsevier Inc. All rights reserved.
            Bookmark
            • Record: found
            • Abstract: not found
            • Article: not found

            Integrin-YAP/TAZ-JNK cascade mediates atheroprotective effect of unidirectional shear flow

              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Angiomotin is a novel Hippo pathway component that inhibits YAP oncoprotein.

              The Yes-associated protein (YAP) is a transcription coactivator that plays a crucial role in organ size control by promoting cell proliferation and inhibiting apoptosis. The Hippo tumor suppressor pathway inhibits YAP through phosphorylation-induced cytoplasmic retention and degradation. Here we report a novel mechanism of YAP regulation by angiomotin (AMOT) family proteins via a direct interaction. Knockdown of AMOT family protein AMOTL2 in polarized Madin-Darby canine kidney (MDCK) cells leads to YAP activation, as indicated by decreased YAP tight junction localization, attenuated YAP phosphorylation, accumulation of nuclear YAP, and induction of YAP target gene expression. Transcriptional coactivator with PDZ-binding motif (TAZ), the YAP paralog, is also regulated by AMOT in a similar fashion. Furthermore, AMOTL2 knockdown results in loss of cell contact inhibition in a manner dependent on the functions of YAP and TAZ. Our results indicate a potential tumor-suppressing role of AMOT family proteins as components of the Hippo pathway, and demonstrate a novel mechanism of YAP and TAZ inhibition by AMOT-mediated tight junction localization. These observations provide a potential link between the Hippo pathway and cell contact inhibition.
                Bookmark

                Author and article information

                Journal
                Proc Natl Acad Sci U S A
                Proc. Natl. Acad. Sci. U.S.A
                pnas
                pnas
                PNAS
                Proceedings of the National Academy of Sciences of the United States of America
                National Academy of Sciences
                0027-8424
                1091-6490
                10 October 2017
                25 September 2017
                : 114
                : 41
                : 10918-10923
                Affiliations
                [1] aDivision of Experimental Hematology and Cancer Biology, Cincinnati Children’s Hospital Medical Center , Cincinnati, OH 45229;
                [2] bDepartment of Pediatrics, College of Medicine, University of Cincinnati , Cincinnati, OH 45229;
                [3] cVisual Systems Group, Abrahamson Pediatric Eye Institute, Division of Pediatric Ophthalmology, Cincinnati Children’s Hospital Medical Center , Cincinnati, OH 45229;
                [4] dDepartment of Ophthalmology, College of Medicine, University of Cincinnati , Cincinnati, OH 45229;
                [5] eDepartment of Molecular Biology, University of Texas Southwestern Medical Center , Dallas, TX 75390;
                [6] fDivision of Pharmaceutical Sciences, James L. Winkle College of Pharmacy, University of Cincinnati , Cincinnati, OH 45267;
                [7] gUCL Institute of Ophthalmology, University College London , London EC1V 9EL, United Kingdom
                Author notes
                1To whom correspondence should be addressed. Email: Mei.Xin@ 123456cchmc.org .

                Edited by Eric N. Olson, University of Texas Southwestern Medical Center, Dallas, TX, and approved August 25, 2017 (received for review March 9, 2017)

                Author contributions: M.S., J.F., R.A.L., and M.X. designed research; M.S., J.F., Y.O., A.H., X.D., P.S., L.B., and M.D. performed research; N.L., X.D., J.H., M.F., Q.R.L., and Y.Z. contributed new reagents/analytic tools; M.S., Y.O., Q.R.L., Y.Z., R.A.L., and M.X. analyzed data; and M.S., R.A.L., and M.X. wrote the paper.

                Article
                PMC5642684 PMC5642684 5642684 201704030
                10.1073/pnas.1704030114
                5642684
                28973878
                d4a9dc5f-1daa-405d-aebf-b8042fc540c2
                History
                Page count
                Pages: 6
                Funding
                Funded by: HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI) 100000050
                Award ID: R01 HL132211-01
                Categories
                Biological Sciences
                Developmental Biology

                CDC42,Hippo signaling,angiogenesis,cell migration
                CDC42, Hippo signaling, angiogenesis, cell migration

                Comments

                Comment on this article